“…The quantitative measurement of brain iron content using QSM has brought into focus the role of iron in the brain development, physical function modulation, and aging (Salami et al, 2018;Peterson et al, 2019), as well as in various neurological diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, metabolic diseases (hepatic encephalopathy and renal encephalopathy), sleep disorders, hematological system diseases, and cerebrovascular diseases (Chai et al, 2015a;Xia et al, 2015;Miao et al, 2018;Chai et al, 2019;Valdés Hernández et al, 2019;Pudlac et al, 2020;Cogswell et al, 2021;Thomas et al, 2021;Zhang et al, 2021;Galea et al, 2022). As iron has been proned to accumulate in the gray matter nuclei in normal people and all these neurological diseases have abnormal iron deposition in the gray matter nuclei, the gray matter nuclei are the critical target structures to explore the abnormal iron deposition.…”